| Emad Abou-arab, MD | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Emad Abou-arab |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225473424 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 11017011A (Indiana) | Secondary |
| 207Q00000X | Family Medicine | MD-43524 (Iowa) | Secondary |
| 207Q00000X | Family Medicine | 4301507137 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Michigan Health System | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
Alkermes plc today announced that the U.S. Food and Drug Administration has granted Fast Track status for ALKS 5461 for the adjunctive treatment of major depressive disorder in patients with an inadequate response to standard therapies.
Vittorio Gallo, PhD, Director of the Center for Neuroscience Research at Children's National Health System, and other researchers have found a "potentially novel therapeutic target" to reduce the rate of deterioration and to promote growth of brain cells damaged by multiple sclerosis (MS). Current therapies can be effective in patients with relapsing MS, but have little impact in promoting tissue growth.
Two decades ago, the landmark Cruzan decision catalyzed individual thinking, policy discussions and lawmaking about advance care directives and choices.
At the College of American Pathologists annual meeting this month, more than 1,300 pathologists will collaborate on the promise, challenges, and questions surrounding immunotherapy—the subject of the opening Scientific Plenary at CAP16 - The Pathologists' Meeting in Las Vegas on Sept. 25.
› Verified 3 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669402848 PECOS PAC ID: 3779496856 Enrollment ID: O20031117000359 |
News Archive
Alkermes plc today announced that the U.S. Food and Drug Administration has granted Fast Track status for ALKS 5461 for the adjunctive treatment of major depressive disorder in patients with an inadequate response to standard therapies.
Vittorio Gallo, PhD, Director of the Center for Neuroscience Research at Children's National Health System, and other researchers have found a "potentially novel therapeutic target" to reduce the rate of deterioration and to promote growth of brain cells damaged by multiple sclerosis (MS). Current therapies can be effective in patients with relapsing MS, but have little impact in promoting tissue growth.
Two decades ago, the landmark Cruzan decision catalyzed individual thinking, policy discussions and lawmaking about advance care directives and choices.
At the College of American Pathologists annual meeting this month, more than 1,300 pathologists will collaborate on the promise, challenges, and questions surrounding immunotherapy—the subject of the opening Scientific Plenary at CAP16 - The Pathologists' Meeting in Las Vegas on Sept. 25.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emad Abou-arab, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Emad Abou-arab, MD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
Alkermes plc today announced that the U.S. Food and Drug Administration has granted Fast Track status for ALKS 5461 for the adjunctive treatment of major depressive disorder in patients with an inadequate response to standard therapies.
Vittorio Gallo, PhD, Director of the Center for Neuroscience Research at Children's National Health System, and other researchers have found a "potentially novel therapeutic target" to reduce the rate of deterioration and to promote growth of brain cells damaged by multiple sclerosis (MS). Current therapies can be effective in patients with relapsing MS, but have little impact in promoting tissue growth.
Two decades ago, the landmark Cruzan decision catalyzed individual thinking, policy discussions and lawmaking about advance care directives and choices.
At the College of American Pathologists annual meeting this month, more than 1,300 pathologists will collaborate on the promise, challenges, and questions surrounding immunotherapy—the subject of the opening Scientific Plenary at CAP16 - The Pathologists' Meeting in Las Vegas on Sept. 25.
› Verified 3 days ago
Ketti Sophia Petersen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. James Robert Neuenschwander, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3131 Professional Dr, Ann Arbor, MI 48104 Phone: 734-995-3200 Fax: 734-995-4254 | |
Ms. Natasha Kristine Nguyen, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1540 E Hospital Dr Spc 5718, Ann Arbor, MI 48109 Phone: 734-936-9777 Fax: 734-936-6897 | |
Ms. Alicia J Cohen, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1801 Briarwood Circle, Ann Arbor, MI 48108 Phone: 734-998-7390 | |
Dana Marie O'neill, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4200 Whitehall Dr Ste 130, Ann Arbor, MI 48105 Phone: 734-995-0303 Fax: 734-995-0425 | |
Karl Thomas Rew, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 24 Frank Lloyd Wright, Lobby H, Ann Arbor, MI 48105 Phone: 734-647-5640 | |
Dr. Noshir Yazdi Amaria, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 207 Fletcher St, Ann Arbor, MI 48109 Phone: 734-764-8320 |